ESTRO 2024 - Abstract Book

S2643

Clinical - Urology

ESTRO 2024

Keywords: hypofractionation, prostate bed, local control

References:

Benziane-Ouaritini N, Zilli T, Giraud A, et al. Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study. Eur Urol Oncol. 2023;6(4):390-398. doi:10.1016/j.euo.2023.02.013 Matrone F, Donofrio A, Fanetti G, et al. Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules. Neoplasma. 2022;69(6):1425-1436. doi:10.4149/neo_2022_220825N864 Widmark A, Gunnlaugsson A, Beckman L, et al. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. Lancet. 2019;394(10196):385-395. doi:10.1016/S0140-6736(19)31131-6 Vale CL, Fisher D, Kneebone A, et al. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. Lancet. 2020;396(10260):1422-1431. doi:10.1016/S0140-6736(20)31952-8

3381

Proffered Paper

Primary endpoint analysis of TRAP, first prospective Phase II trial of SBRT to oligoprogressive disease prostate cancer (NCT03644303) Priyanka Patel 1 , Sabine Dreibe 2 , Gerhardt Attard 3 , Aidan J Cole 4 , John Frew 5 , Jean Guevara 2 , Vinod Mullassery 6 , Julia Murray 1 , Chris Parker 1 , Nachi Palaniappan 7 , Angela Pathmanathan 1 , Alison Reid 1 , Yae-Eun Suh 1 , Isabel Sundikus 8 , Angelie Tirona 2 , Amina Tran 2 , Nina Tunariu 9 , James Wylie 10 , Alison C Tree 11,12 1 Royal Marsden NHS Foundation Trust, Uro-Oncology, London, United Kingdom. 2 Royal Marsden NHS Foundation Trust, Royal Marsden clinical trials unit, London, United Kingdom. 3 University College London Cancer Institute, Uro Oncology, London, United Kingdom. 4 Queen's University Belfast, Uro-Oncology, Belfast, United Kingdom. 5 Newcastle upon Tyne Hospital NHS Foundation Trust, Uro-Oncology, Newcastle Upon Tyne, United Kingdom. 6 Guy's and St Thomas' NHS Foundation Trust, Uro-Oncology, London, United Kingdom. 7 Velindre Cancer Centre, Uro-Oncology, Cardiff, United Kingdom. 8 The Clatterbridge Cancer Centre NHS Foundation Trust, Uro-Oncology, Wirral, United Kingdom. 9 Royal Marsden NHS Foundation Trust, Radiology, London, United Kingdom. 10 The Christie NHS Foundation trust, Uro-Oncology, Manchester, United Kingdom. 11 Royal Marsden NHS Foundation Trust, Uro oncology, London, United Kingdom. 12 Institute of Cancer Research, Uro- Oncology, London, United Kingdom

Purpose/Objective: